2009). The FDA as a Public Health Agency. New Engl J Med, 360 (24), 2493–5.
1997). Clinical Trials: A Methodologic Perspective. New York: John Wiley & Sons.
2009). A difficult balance – pain management, drug safety, and the FDA. New Engl J Med, 361 (22), 2105–7.
2004). Innovation/Stagnation, Challenge and Opportunity on the Critical Path to New Medical Products. March 2004.
. REMS Assessments and Proposed REMS Modifications.
: Review Time Has Decreased in Recent Years,
The views are those of the author and not necessarily those of the Food and Drug Administration.